Your browser is no longer supported. Please, upgrade your browser.
Settings
PRPO [NASD]
Precipio, Inc.
Index- P/E- EPS (ttm)-1.29 Insider Own0.10% Shs Outstand17.58M Perf Week-11.79%
Market Cap37.83M Forward P/E- EPS next Y-0.38 Insider Trans14.40% Shs Float17.03M Perf Month-20.16%
Income-14.00M PEG- EPS next Q-0.10 Inst Own4.40% Short Float4.63% Perf Quarter-15.83%
Sales6.10M P/S6.20 EPS this Y63.50% Inst Trans39.65% Short Ratio1.04 Perf Half Y-12.17%
Book/sh0.80 P/B2.52 EPS next Y- ROA-70.30% Target Price- Perf Year240.07%
Cash/sh0.14 P/C14.01 EPS next 5Y20.00% ROE-107.70% 52W Range0.55 - 8.00 Perf YTD-2.42%
Dividend- P/FCF- EPS past 5Y70.90% ROI-67.30% 52W High-74.75% Beta2.69
Dividend %- Quick Ratio0.80 Sales past 5Y25.90% Gross Margin18.90% 52W Low267.27% ATR0.20
Employees54 Current Ratio0.90 Sales Q/Q171.40% Oper. Margin- RSI (14)36.97 Volatility8.81% 8.93%
OptionableNo Debt/Eq0.09 EPS Q/Q79.00% Profit Margin- Rel Volume0.41 Prev Close1.96
ShortableYes LT Debt/Eq0.04 EarningsMar 31 AMC Payout- Avg Volume755.85K Price2.02
Recom2.00 SMA20-13.52% SMA50-24.02% SMA200-13.66% Volume312,628 Change3.06%
Apr-05-21 09:00AM  
Mar-31-21 03:15PM  
Mar-30-21 09:00AM  
Mar-18-21 04:30PM  
Mar-03-21 01:00PM  
11:00AM  
Jan-28-21 09:30AM  
Jan-20-21 10:00AM  
Dec-10-20 10:15AM  
Nov-19-20 03:15PM  
Nov-11-20 09:00AM  
Oct-06-20 10:00AM  
Sep-22-20 10:30AM  
Sep-04-20 09:00AM  
Aug-20-20 01:00PM  
Aug-07-20 09:00AM  
Aug-04-20 10:45AM  
Jul-31-20 07:45AM  
Jul-30-20 10:15AM  
Jul-22-20 10:15AM  
Jul-01-20 02:00PM  
Jun-09-20 10:00AM  
May-19-20 03:00PM  
May-15-20 10:00AM  
May-12-20 05:00PM  
Apr-20-20 02:28AM  
Apr-13-20 02:27PM  
Apr-06-20 10:00AM  
Mar-20-20 09:30AM  
Mar-16-20 09:30AM  
Feb-26-20 11:30AM  
Feb-18-20 10:00AM  
Jan-28-20 09:00AM  
07:30AM  
Jan-15-20 07:30AM  
Jan-13-20 05:00PM  
Dec-17-19 10:30AM  
Dec-04-19 09:15AM  
Nov-14-19 12:15PM  
09:15AM  
Nov-04-19 05:30PM  
Oct-09-19 12:00PM  
Oct-02-19 04:30PM  
Sep-30-19 11:10AM  
Sep-27-19 04:28PM  
03:08PM  
Sep-26-19 10:53AM  
Sep-05-19 09:15AM  
Aug-21-19 03:00PM  
Aug-13-19 11:30AM  
09:15AM  
Jul-22-19 10:00AM  
Jun-25-19 09:15AM  
Jun-17-19 10:39AM  
Jun-04-19 09:10AM  
May-30-19 10:15AM  
May-23-19 09:55AM  
May-15-19 11:40AM  
May-06-19 09:20AM  
May-03-19 09:11AM  
May-01-19 06:06PM  
Apr-29-19 12:02PM  
08:35AM  
Apr-26-19 11:00AM  
Apr-24-19 09:01AM  
Apr-18-19 08:45AM  
Apr-15-19 09:15AM  
Apr-09-19 09:15AM  
Apr-03-19 07:38AM  
Mar-27-19 07:47AM  
Mar-11-19 08:45AM  
Mar-05-19 07:40AM  
Feb-18-19 05:00PM  
Feb-14-19 08:18AM  
Jan-29-19 07:47AM  
Jan-15-19 07:47AM  
Jan-14-19 08:00AM  
Jan-10-19 07:45AM  
Jan-08-19 07:45AM  
Dec-12-18 08:15AM  
Dec-04-18 09:15AM  
Nov-27-18 10:10AM  
09:38AM  
Nov-16-18 09:32AM  
Nov-15-18 09:00AM  
Nov-14-18 09:30AM  
09:15AM  
Nov-01-18 09:15AM  
Oct-23-18 09:15AM  
Oct-18-18 07:36AM  
Oct-16-18 07:47AM  
Oct-03-18 07:47AM  
Sep-27-18 07:37AM  
Sep-21-18 09:18AM  
Sep-20-18 07:37AM  
Aug-23-18 07:00AM  
Aug-22-18 09:45PM  
Aug-17-18 07:37AM  
Aug-09-18 07:37AM  
Jul-19-18 08:10AM  
Precipio, Inc., a cancer diagnostics and reagent technology company, provides diagnostic products and services in the United States oncology market. Its product consists of clinical diagnostic services. The company's clinical diagnostic services focus on the diagnosis of different hematopoietic or blood-related cancers to oncologists. Its cytogenetics media IV-Cell enables laboratories to arrive at more accurate results; HemeScreen panel enables hospitals and laboratories to run an important genetic mutation test; and ICE-COLD-PCR enables detection of abnormalities in blood samples. The company also operates a cancer diagnostic laboratory located in New Haven, Connecticut. It sells ICE-COLD-PCR technology kits to bio-pharma customers, clinical research, HemeScreen, and COVID-19 antibody tests. The company serves oncologists, hospitals, reference laboratories, physician-office labs, and pharma and biotech companies. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, such as the Yale School of Medicine, Harvard's Dana-Farber Cancer Institute, and the University of Pennsylvania. The company is based in New Haven, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DANIELI ILANChief Executive OfficerMar 01Buy2.461,0252,52221,462Mar 03 05:20 PM
Sabet Ahmed ZakiChief Operating OfficerDec 01Buy2.232224954,728Dec 03 04:31 PM
DANIELI ILANChief Executive OfficerDec 01Buy2.231,1112,47820,437Dec 03 04:31 PM
Sabet Ahmed ZakiChief Operating OfficerSep 01Buy2.161302814,506Sep 03 09:10 PM
DANIELI ILANChief Executive OfficerSep 01Buy2.151,1502,46719,326Sep 03 09:09 PM
Sabet Ahmed ZakiChief Operations OfficerJul 07Buy0.962812704,207Jul 14 04:15 PM
Sabet Ahmed ZakiChief Operations OfficerJul 07Buy1.601692704,376Jul 14 04:16 PM
DANIELI ILANChief Executive OfficerJul 06Buy0.962,5852,48218,176Jul 07 04:31 PM
DANIELI ILANChief Executive OfficerJul 06Buy1.601,5502,48015,591Jul 07 04:30 PM